GlassScriptPhysician profile
Arun Agarwal
NPI 1326226044
$15,116.17
in general payments reported to CMS, 2019-2025
50 companies · $3,581 in 2025
The $3,581 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,869 · 2020: $363 · 2021: $402 · 2022: $2,136 · 2023: $2,432 · 2024: $3,333 · 2025: $3,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,328 · Education: $17.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,327.87 |
| Education | $17.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,380.96 | 2019-2025 | Jot Dx, Cardiomems, Gallant |
| Novartis Pharmaceuticals Corporation | $1,376.78 | 2019-2025 | |
| Amgen INC. | $1,115.84 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $1,014.86 | 2019-2025 | |
| Novo Nordisk INC | $979.28 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $874.10 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $837.10 | 2022-2025 | Watchman Flx, Watchman Access System, Watchman |
| Janssen Pharmaceuticals, INC | $806.65 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $755.38 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $706.05 | 2019-2025 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $595.75 | 2022-2025 | Verquvo, Winrevair |
| Impulse Dynamics (USA) INC. | $409.23 | 2022-2024 | Optimizer, Optimizer |
| Alnylam Pharmaceuticals INC. | $392.60 | 2022-2025 | Amvuttra, Onpattro |
| Esperion Therapeutics, INC. | $317.26 | 2021-2025 | Nexletol |
| Glaxosmithkline, LLC. | $263.72 | 2019-2025 | Nucala, Shingrix |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $261.99 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $248.96 | 2019-2023 | |
| Heartflow, INC. | $220.45 | 2023-2025 | Ffrct |
| Bridgebio Pharma, INC. | $211.34 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $200.69 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Biotronik INC. | $178.34 | 2019-2022 | |
| Ekos Corporation | $144.06 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $127.25 | 2023-2025 | Lifevest |
| United Therapeutics Corporation | $121.84 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $121.38 | 2024-2025 | Evkeeza |
| Corcept Therapeutics | $117.95 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $107.51 | 2023-2024 | Inpefa |
| Inspire Medical Systems, INC. | $106.95 | 2024 | Inspire |
| Abiomed | $103.42 | 2024-2025 | Impella |
| Lundbeck LLC | $90.08 | 2019 | |
| Medtronic, INC. | $83.20 | 2025 | Symplicity G3 |
| Bayer Healthcare Pharmaceuticals INC. | $82.49 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $71.73 | 2024 | Arcalyst |
| Medicomp INC | $70.76 | 2024 | Telepatch Cardiac Monitor |
| Atricure, INC. | $69.83 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Omeros Corporation | $69.32 | 2019 | |
| Daiichi Sankyo INC. | $64.27 | 2019-2023 | Injectafer |
| Preventice Services, LLC | $56.60 | 2019 | |
| Vifor Pharma, INC. | $46.62 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $43.81 | 2019 | |
| Lilly USA, LLC | $40.23 | 2025 | Mounjaro, Zepbound |
| Nuvasive, INC. | $39.27 | 2019 | |
| Philips North America LLC | $37.84 | 2022 | |
| Scpharmaceuticals INC. | $34.24 | 2023-2024 | |
| Chiesi USA, INC. | $33.93 | 2024 | Juxtapid |
| Irhythm Technologies, INC. | $25.29 | 2023 | Zio Xt Patch |
| Astellas Pharma US INC | $20.99 | 2019 | |
| Allergan, INC. | $13.95 | 2019 | |
| Genentech USA, INC. | $12.59 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $11.44 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.